Specialty Pharmacy
The fastest-growing segment of pharmacy spend. Biosimilars, gene therapy, GLP-1s, and the networks that deliver them.
Specialty Pharmacy Explained
What qualifies as a specialty drug, how they are distributed, and why they now represent over 50% of pharmacy spending.
Biosimilars Guide
Biologic copies that can reduce costs by 30-60%. FDA approval pathways, interchangeability, and adoption barriers.
Cell & Gene Therapy
Million-dollar cures creating new financing challenges. Outcomes-based contracts and reinsurance strategies for employers.
The GLP-1 Cost Crisis
Ozempic, Wegovy, and Mounjaro are reshaping pharmacy budgets. The utilization surge and employer response strategies.